• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

DuPont Has the Right Chemistry for a Rally: Our Strategy From the Charts

A technical look at two chemical stocks: DuPont and Olin.
By BRUCE KAMICH
Jul 23, 2020 | 11:35 AM EDT
Stocks quotes in this article: OLN, DD

During Wednesday night's Lightning Round segment of Mad Money one caller asked host Jim Cramer about Olin (OLN) . "If you want a chemical company, you want DuPont (DD) . This one has been a disappointment," replied Cramer. Let's take a look at the charts and indicators of DD after a quick look at OLN.

In this daily bar chart of OLN, below, we can see a relatively weak picture with prices staying below the declining 200-day moving average line the past 12 months and now trading around the declining 50-day moving average line.

In the daily bar chart of DD, below, we can see a more positive-looking picture. Here prices are above the rising 50-day moving average line. Prices are also above the bottoming 200-day moving average line.

The daily On-Balance-Volume (OBV) line has been positive since late March telling us that buyers of DD have been more aggressive. The trend-following Moving Average Convergence Divergence (MACD) oscillator looks like it is bottoming above the zero line in preparation for a new buy signal.

In this weekly bar chart of DD, below, we can see a positive picture with prices edging above the bottoming 40-week moving average line.

The weekly OBV line has come off its low and the MACD oscillator is now close to crossing above the zero line for an outright buy signal.

In this daily Point and Figure chart of DD, below, we can see a potential upside price target in the $63 area.

Bottom-line strategy: DD looks attractive from the long side. Traders should risk a close below $50 and add on strength. The $63 area is our first target followed by the $75 area.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | Markets | Stocks | Technical Analysis | Trading

More from Stocks

7 Biotech Stocks I'm Buying As They Lead a Market Bounce

James "Rev Shark" DePorre
Jul 7, 2022 11:56 AM EDT

It has been a mistake to trust momentum to last in this environment.

Here's Where Shares of Walmart Are Attracting Buyers

Bruce Kamich
Jul 7, 2022 11:45 AM EDT

Only nimble traders need apply.

Kass: Why I'm Aggressively Buying Bank and Brokerage Stocks

Doug Kass
Jul 7, 2022 11:30 AM EDT

For me, it's the time to be an opportunistic buyer

Roblox: You Don't Have to Imagine That a Base Has Developed

Bruce Kamich
Jul 7, 2022 11:10 AM EDT

Here's the trade.

Seagen Is Being Hotly Pursued By Merck: Here's the Trade

Stephen Guilfoyle
Jul 7, 2022 11:00 AM EDT

SGEN is a biotech with leadership precisely where big pharma wants to go.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:41 AM EDT STEPHEN GUILFOYLE

    Reweighting Portfolio Positions Through 5 Trades

    Check out what we're doing in the TheStreet's Stoc...
  • 12:01 PM EDT PAUL PRICE

    A Recent Director Buy in Children's Place (PLCE)

    Four of the most recent insider trades in Children...
  • 07:34 AM EDT PAUL PRICE

    A $525,000 Vote of Confidence on Macerich (MAC)

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login